Core Insights - Berkshire Hathaway Inc is nearing a deal to acquire Occidental Petroleum Corp's petrochemical business for approximately $10 billion, marking its largest deal since the acquisition of Alleghany Corp in 2022 for $13.7 billion [1][2] Group 1: Deal Details - The transaction could be announced in the coming days, with discussions being confidential [1] - Occidental has been involved in nearly $4 billion of asset sales since the beginning of last year to reduce debt [3] Group 2: Financial Performance - OxyChem, Occidental's petrochemical division, is expected to generate pretax income of $800 million to $900 million this year [4] - Berkshire Hathaway's cash reserves totaled $344 billion at the end of June, close to a record high [3] Group 3: Strategic Moves - Warren Buffett appears to be returning to aggressive deal-making after a period of refraining from large transactions, having recently invested $1.6 billion in UnitedHealth Group Inc [2]

Core Viewpoint - UnitedHealth Group Inc. experienced a significant stock increase of 12% in morning trading, indicating a potential recovery after a challenging year, and is expected to contribute approximately 209 points to the Dow Jones Industrial Average at Friday's open [1]. Company Performance - Shares of UnitedHealth were down nearly 50% for 2025 through Thursday's close, reflecting the company's struggles amid rising healthcare costs and public backlash [2]. - The company previously withdrew its annual earnings outlook, and CEO Andrew Witty stepped down, which contributed to a negative market perception [3]. - A new 2025 outlook provided by UnitedHealth fell short of Wall Street estimates, further impacting the stock negatively [3]. Market Sentiment - Berkshire Hathaway's investment in UnitedHealth is viewed as a significant vote of confidence, potentially stabilizing the stock and encouraging other investors to consider the managed care organization (MCO) sector as a safe investment opportunity [4].

Group 1: UnitedHealth Group Inc. (UNH) - UnitedHealth's shares have outperformed the Zacks Medical - HMOs industry over the past year, with a growth of 1% compared to a decline of 3.4% in the industry [4] - The company's revenue growth is supported by a strong market position, new deals, renewed agreements, and expansion of service offerings [4] - Adjusted net earnings per share are anticipated to be in the range of $29.50 to $30 for 2025, backed by a sturdy balance sheet that allows for investments and capital deployment through buybacks and dividends [5] Group 2: SAP SE (SAP) - SAP's shares have outperformed the Zacks Computer - Software industry over the past year, with a growth of 48% compared to 2.6% in the industry [7] - The company is benefiting from growing cloud demand, particularly through its Rise with SAP and Grow with SAP solutions, which are driving cloud revenues [7] - SAP's revised 2025 outlook expects cloud and software sales to be in the range of €33.1 billion to €33.6 billion, an increase from the previous forecast of €29.83 billion [9] Group 3: Toyota Motor Corp. (TM) - Toyota Motor's shares have outperformed the Zacks Automotive - Foreign industry over the past six months, with a growth of 9.3% compared to 9% in the industry [10] - The surge in hybrid adoption is driving sales, supported by strategic initiatives aimed at growth and profitability [10] - Significant investments in human capital and expansion initiatives are expected to weigh on operating profits this fiscal year, alongside rising debt levels [12] Group 4: Better Choice Company Inc. (BTTR) - Better Choice has underperformed the Zacks Retail - Miscellaneous industry over the past year, with a decline of 75% compared to 8.2% in the industry [13] - The company achieved its first profitable quarter in Q3 2024, with adjusted EBITDA exceeding $0.2 million and gross margins reaching 40% [14] - The Asia-Pacific market remains a key driver for growth, supported by trends in pet ownership and demand for premium brands [15]